Skip to main content

Cardiovascular Drugs and Therapy

Ausgabe 1/2004

Inhalt (13 Artikel)

Editorial Board

From the Editor

Willem J. Remme

Editorial Introduction

Remodeling as an End-Point in Heart Failure Therapy

Jay N. Cohn

Editorial Introduction

Cholesterol and Coronary Disease—The Altered Landscape

John C. LaRosa

Nicorandil Protects Against Lethal Ischemic Ventricular Arrhythmias and Up-regulates Endothelial Nitric Oxide Synthase Expression and Sulfonylurea Receptor 2 mRNA in Conscious Rats with Acute Myocardial Infarction

Shigeo Horinaka, Naohiko Kobayashi, Akihisa Yabe, Hiroshi Asakawa, Hiroshi Yagi, Yousuke Mori, Yusuke Tsubokou, Koutarou Yoshida, Shigefumi Nakano, Hiroaki Matsuoka

17ß Oestradiol Does Not Attenuate the Response to Angiotensin I and II During Long Term Therapy in Postmenopausal Women

Pardeep S. Jhund, Nuala Dawson, Andrew P. Davie, John Norrie, Kevin P.J. O’Kane, John J.V. McMurray

The Benefits of Early Combination Treatment of Carvedilol and an ACE-Inhibitor in Mild Heart Failure and Left Ventricular Systolic Dysfunction. The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial (CARMEN)

Willem J. Remme, Guenter Riegger, Per Hildebrandt, Michel Komajda, Wybren Jaarsma, Marco Bobbio, Jordi Soler-Soler, Armin Scherhag, Beatrix Lutiger, Lars Rydén

Fluvastatin Reduces Cardiac Mortality in Patients with Coronary Heart Disease

Christie M. Ballantyne, Günter Riegger, Nicholas Moore, Francesco Saia, Patrick W.J.C. Serruys

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.